Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
SURYADEVARA ET AL., 2021. CELL 184(9): 2316-2331.
RESOURCES
Where research scientists come to find up to date resources on antibody discovery against challenging membrane protein targets.
Menu
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
KU ET AL. 2021. NATURE COMM 12(469).
A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies
GRAHAM ET AL. 2021. J VIROL DOI: 10.1128/JVI.02423-20.
Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins
CHEN ET AL., 2021. IMMUNITY 54(4): 781-796.
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
MURIN ET AL. 2021. CELL REP 35(2).
Brain-specific angiogenesis inhibitor 1 is expressed in the Myo/Nog cell lineage
GERHART ET AL. 2020. PLoSONE 15(7):e0234792.
Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics
GILCHUK ET AL. 2020. NATURE BIOMED ENG 4:1030-1043.
Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications
WHITBECK ET AL. 2020. PLoS NEGL TROP DIS 14(11): e0008730.
Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor
DUSSUPT ET AL. 2020. NATURE MED 26:228-235.
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies
ILINYKH ET AL. 2020. CELL HOST MICROBE S1931-3128(20)30189
